Download PDF
Diabetologie und Stoffwechsel 2008; 3(1): 51-55
DOI: 10.1055/s-2008-1004640
Übersichtsarbeit

© Georg Thieme Verlag Stuttgart · New York

Kann die niedrig dosierte subkutane Glukagon-Gabe schwere Hypoglykämien bei Typ-1-Diabetes im Kindesalter verhindern und die Hospitalisationsrate senken?

Is there a Role for Subcutaneous “Mini-Dose-Glucagon” Application in Younger Children with Type 1 Diabetes to Avoid Severe Hypoglycaemia and to Decrease Hospitalization Rate?S. Lienert1 , J. Hamann1 , R. Herterich1
  • 1Kinderklinik St. Marien, Landshut, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München (LMU) München; anerkanntes Behandlungszentrum der Deutschen Diabetologischen Gesellschaft
Further Information

Publication History

2007

2007

Publication Date:
13 February 2008 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Eine adäquate Stoffwechseleinstellung des Diabetes mellitus Typ 1 (IDDM / T1DM) bei Kindern wird durch Hypoglykämien erschwert. In der Pädiatrie treten Hypoglykämien häufig im Rahmen von Gastroenteritiden oder nach Insulingabe und ausbleibender Kohlenhydrataufnahme auf. Eine orale Therapie mit festen oder flüssigen Kohlenhydraten ist nicht immer möglich. Glukagon ist anerkanntes Notfallmedikament bei Hypoglykämien, in der Standarddosierung aber mit Nebenwirkungen behaftet. Unter Umständen ist eine stationäre Therapie notwendig, die für Kind und Eltern belastender sein kann. Stellt die im angloamerikanischen Raum praktizierte Mini-Dose-Glukagon-Rescue-Gabe bei leichten bis mittleren Hypoglykämien eine kindgerechte therapeutische Alternative dar? Lassen sich schwere Hypoglykämien verhindern bzw. lässt sich die Hospitalisationsrate verringern?

Abstract

An adequate glycaemic control in type 1 diabetes paediatric patients is limitated by hypoglycaemia. In paediatric patients, hypoglycaemia often occurs with gastroenteritis or if carbohydrate intake after insulin injection is rejected. Oral intake of solid or liquid carbohydrates is not always possible. Glucagon is standard emergency treatment of hypoglycaemia, however, associated with adverse effects when given at standard dose. Owing to the circumstances, admission to clinic might be required being possibly more stressful to children and parent. Is subcutaneous “Mini-Dose-Glucagon” application in younger children with type 1 diabetes feasible in mild or impending hypoglycaemia to avoid severe hypoglycaemia and to decrease hospitalization rate?

Schlüsselwörter

Diabetes mellitus - Hypoglykämie - Behandlung - Glukagon - Mini-Dose-Glucagon-Rescue - Hospitalisierung

Key words

diabetes mellitus - hypoglycaemia - treatment - mini-dose-glucagon-rescue - hospitalization

Literatur

  • 1 Danne T, Beyer P, Holl W, Kiess W, Kordonurie K, Lange K, Lepler R, Marg W, Neu A, Petersen M, Ziegler R. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter.  Diabetes und Stoffwechsel. 2004;  13 (Suppl 2) -Leitlinie
    Google Scholar
  • 2 Bolli G B. Mechanisms, Treatment, and Prevention of Hypoglycaemia unawareness in T1DM.  International Diabetes Monitor Archieves. 2003;  1-8
    Google Scholar
  • 3 Cryer P E. Associated-associated autonomic failure in diabetes.  Am J Physiol Endocrinol Metab. 2001;  281 E1115-E1121
    Google Scholar
  • 4 Fanelli C G, Epifano L, Rambotti A M, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P. Meticulous prevention of hypoglycaemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycaemia in intensively treated patients with short-term IDDM.  Diabetes. 1993;  42 1683-1689
    CrossrefGoogle Scholar
  • 5 Jones T W, Davis E. Hypoglycaemia in children with type 1 diabetes: current issues and controversies.  Pediatric Diabetes. 2003;  4 143-150
    CrossrefGoogle Scholar
  • 6 Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycaemia unawareness by asymptomatic nocturnal hypoglycaemia.  Diabetes. 1993;  42 1233-1237
    CrossrefGoogle Scholar
  • 7 Cryer P, Karl I, Karl M. Hypoglycaemia - Pathophysiology, Diagnosis, and Treatment. Washington University School of Medicine: Oxford University Press 1997; 1-198
    Google Scholar
  • 8 NHS, NLH .Is there any evidence that buccal dextrose gel (Hypostop or Glucogel) is of any use in hypoglycaemic reactions? - The NICE guideline on the management of type 1 diabetes refers to Hypostop in the following context.  http://www.clinicalanswers.nhs.uk/index.cfm&?question=1272 NHS (National Health Service); NLH (National Library of Health). 2007
    Google Scholar
  • 9 Fonseca B K, Holdgate A, Craig J C. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials.  Arch Pediatr Adolesc Med. 2004;  158 483-490
    CrossrefGoogle Scholar
  • 10 FachInfo-Service .Novo Nordisk GlucaGen / GlucaGen HypoKit.  www.fachinfo.de, 1-3. 2006. Fachinformation (Zusammenfassung der Produkteigenschaften)
    Google Scholar
  • 11 Monsod T PC, Tamborlane W V, Coraluzzi L, Bronson M, Yong-Zhan Ma T, Ahern J A. Epipen as an alternative to glucagon in the treatment of hypoglycaemia in children with diabetes.  Diabetes Care. 2001;  24 701-704
    CrossrefGoogle Scholar
  • 12 Giani G, Gia, Rosenbauer J, Icks A. Typ 1-Diabetes mellitus (1.1.1999-31.12.1999). (in ESPED Jahresbericht 1999)
    Google Scholar
  • 13 Icks A, Rosenbauer J, Haastert B, Rathmann W, Grabert M, Gandjour A, Giani G, Holl R W. Direct costs of pediatric diabetes care in Germany and their predictors.  Exp Clin Endocrinol Diabetes. 2004;  112 302-309
    Article in Thieme ConnectGoogle Scholar
  • 14 Icks A, Rosenbauer J, Rathmann W, Haastert B, Gandjour A, Giani G. Direct costs of care in germany for children and adolescents with diabetes mellitus in the early course after onset.  J Pediatr Endocrinol Metab. 2 004;  7 1551-1559
    Google Scholar
  • 15 Huerter P, Danne T. Hypoglykämie. In: Diabetes bei Kindern und Jugendlichen. Springer, 6. Auflage 2004; 424-454
    Google Scholar
  • 16 Lteif A N, Schwenk II F. Type 1 diabetes mellitus in early childhood: glycemic control and associated risk of hypoglycemic reactions.  Mayo Clin Proc. 1999;  74 211-216
    Google Scholar
  • 17 ISPAD, IDF, WHO .Consensus guideline for the management of insulin-dependent (type I) diabetes mellitus (IDDM) in childhood and adolescence.  www.ispad.org, deutsche Fassung: www.disetronic.de/download/0701_B_ISPAD.pdf. 2000
    Google Scholar
  • 18 Bolli G B, Fanelli C G. Physiology of glucose counterregulation to hypoglycaemia.  Endocrinol Metab Clin North Am. 1999;  28 467-493
    Google Scholar
  • 19 Matyka K A, Crowne E C, Havel P J, Macdonald I A, Matthews D, Dunger D B. Counterregulation during spontaneous nocturnal hypoglycaemia in prepubertal children with type 1 diabetes.  Diabetes Care. 1999;  22 1144-1150
    CrossrefGoogle Scholar
  • 20 Chase H. Understanding Diabetets - Department of Pediatrics. 10 ed. 2002; 1-325
    Google Scholar
  • 21 Karow T, Lang-Roth R. Antidiabetika. In: Allgemeine und Spezielle Pharmakologie und Toxikologie 2003 - Vorlesungsorientierte Darstellung und klinischer Leitfaden. 2003; 518-535
    Google Scholar
  • 22 Bolli G B. From physiology of glucose counterregulation to prevention of hypoglycaemia in type 1 diabetes.  Diabetes Nutr Metab. 1990;  4 333-349
    Google Scholar
  • 23 Brambilla P, Bougneres P F, Santiago J V, Chaussain J L, Pouplard A, Castano L. Glucose counterregulation in pre-school-age diabetic children with recurrent hypoglycaemia during conventional treatment.  Diabetes. 1987;  36 300-304
    CrossrefGoogle Scholar
  • 24 Caplin N, Johnston R, Jones T, Davis E. Early and permanent loss of the glucagon response to hypoglycaemia in adolescents with Type 1 diabetes. International Diabetes Federeation Congress Poster Nr. 2243. 2003
    Google Scholar
  • 25 Gerich J E, Langlois M, Noacco C, Karam J H, Forsham P H. Lack of glucagon response to hypoglycaemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.  Science. 1973;  182 171-173
    Google Scholar
  • 26 Jones T W, Boulware S D, Kraemer D T, Caprio S, Sherwin R S, Tamborlane W V. Independent effects of youth and poor diabetes control on responses to hypoglycaemia in children.  Diabetes. 1991;  40 358-363
    CrossrefGoogle Scholar
  • 27 Dagogo-Jack S, Rattarasarn C, Cryer P E. Reversal of hypoglycaemia unawareness, but not defective glucose counterregulation, in IDDM.  Diabetes. 1994;  43 1426-1434
    CrossrefGoogle Scholar
  • 28 Heller S R, Cryer P E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycaemia after 1 episode of hypoglycaemia in nondiabetic humans.  Diabetes. 1991;  40 223-226
    Google Scholar
  • 29 Lingenfelser T, Renn W, Sommerwerck U, Jung M F, Buettner U W, Zaiser-Kaschel H, Kaschel R, Eggstein M, Jakober B. Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycaemia in IDDM patients.  Diabetes. 1993;  42 610-618
    Google Scholar
  • 30 Boland E, Monsod T, Delucia M, Brandt C A, Fernando S, Tamborlane W V. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.  Diabetes Care. 2001;  24 1858-1862
    Google Scholar
  • 31 Deiss D, Kordonouri O, Meyer K, Danne T. Long hypoglycaemic periods detected by subcutaneous continuous glucose monitoring in toddlers and pre-school children with diabetes mellitus.  Diabet Med. 2001;  18 337-338
    CrossrefGoogle Scholar
  • 32 Porter P A, Keating B, Byrne G, Jones T W. Incidence and predictive criteria of nocturnal hypoglycaemia in young children with insulin-dependent diabetes mellitus.  J Pediatr. 1997;  130 366-372
    Google Scholar
  • 33 Tupola S, Rajantie J. Documented symptomatic hypoglycaemia in children and adolescents using multiple daily insulin injection therapy.  Diabet Med. 1998;  15 492-496
    CrossrefGoogle Scholar
  • 34 Huerter P, Danne T. Praxis der Insulinbehandlung - Akute Infektionen bei Kinder und Jugendlichen mit Diabetes. In: Diabetes bei Kindern und Jugendlichen. Springer, 6. Auflage 2004; 380-389
    Google Scholar
  • 35 Reid S, Losek J. Hypoglycaemia complicating dehydration in children with acute gastroenteritis.  Journal of Emergency Medicine. 2005;  29 (2) 141-145
    CrossrefGoogle Scholar
  • 36 Frier B M. Glucagon and hypoglycaemia (advertising feature).  J Clin Endocrinol Metab. 2007;  92 1581-1994
    CrossrefGoogle Scholar
  • 37 Novo Nordisk Pharma AG .GlucaGen® Hypo-Kit.  http://chg.novonordisk.ch/documents/article_page/document/diab_glucagen_hypokit.asp. 2007
    Google Scholar
  • 38 Lienert S. “Mini-Dose Glucagon Rescue for Hyperglycemia”. Praktische Erfahrungen aus einem Gastarztaufenthalt am Childrens Memorial Hospital, Chicago, USA. 2005. Qualitätszirkel Kinderdiabetologie Südbayern, v. Haunersche Kinderspital, Munich, Germany
    Google Scholar
  • 39 Haymond M W, Schreiner B. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.  Diabetes Care. 2001;  24 643-645
    CrossrefGoogle Scholar
  • 40 Hartley M, Thomsett M J, Cotterill A M. Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: the Brisbane experience.  J Paediatr Child Health. 2006;  42 108-111
    Google Scholar
  • 41 Haymond M W. Glycemic rescue using mini-dose glucagon in managing gastroenteritis in children with IDDM (Abstract).  Diabetes. 1996;  45 (Suppl. 2) 264 A-264A
    Google Scholar
  • 42 Hasan K S, Kabbani M. Mini-dose glucagon is effective at diabetes camp.  J Pediatr. 2004;  144 834
    Google Scholar
  • 43 Children with Diabates .Mini-Dose Glucagon Rescue.  http://www.childrenwithdiabetes.com/d_0j_20w.htm. 2007
    Google Scholar
  • 44 Edelman S, Isley W, Schwartz S, Fonseca V, Mudaliar S, Henry S. Subcutaneous infusion of very low dose-glucagon averts insulin induced hypoglycaemia in patients with type 1 diabetes mellitus. 42nd EASD Annual Meeting, Kopenhagen 2006.  Diabetologia. 2006;  49 (Suppl. 1) 506 , (Abstract No. 0834)
    CrossrefGoogle Scholar
  • 45 Laffel L. Sick-day management in type 1 diabetes.  Endocrinol Metab Clin North Am. 2000;  29 707-723
    CrossrefGoogle Scholar
  • 46 Battelino T. Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents.  Pediatric Diabetes. 2006;  7 20-24
    CrossrefGoogle Scholar
  • 47 Deiss D, Bolinder J, Riveline J-P, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in Poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.  Diab Care. 2006;  29 (12) 2730-2732
    CrossrefGoogle Scholar

S. F. Lienert

Assistenzarzt f. KinderheilkundeHealth Care Manager

Jakob-Klar-Str. 6

80796 München

Email: sven.lienert@gmx.de